CKD-519 + rosuvastatin

CKD-519 + rosuvastatin is a **combination of two drugs**: CKD-519, a cholesteryl ester transfer protein (CETP) inhibitor, and rosuvastatin, a statin that inhibits HMG-CoA reductase. This combination is being evaluated for their interaction and lipid-lowering effects in clinical studies, particularly in the context of dyslipidemias. CKD-519 is designed to raise HDL cholesterol by inhibiting CETP, whereas rosuvastatin lowers LDL cholesterol by inhibiting the rate-limiting enzyme of cholesterol synthesis. There are no indications that this combination is marketed as a fixed-dose product; rather, it is being investigated in clinical drug interaction studies in healthy subjects and potentially for use in lipid disorders[1][3][5].

Brand names

CrestorEzallor Sprinkle

Other names

rosuvastatin calciumRocacetrapib